GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by ...
Nexi SpA (NEXXY) reported a 5.6% revenue growth for the first nine months of 2024, with merchant solutions revenues up by 6.9%. EBITDA increased by 7.3% year-to-date, with an 82 basis point ...